Epinastine
Jump to navigation
Jump to search
Names | |
---|---|
Trade names | Alesion, Elestat, Purivist, Relestat |
Other names | Epinastine hydrochloride |
| |
Clinical data | |
Drug class | Antihistamine[1] |
Main uses | Allergic conjunctivitis[1] |
Side effects | Eye irritation[2] |
Pregnancy category |
|
Routes of use | Eye drops |
Onset of action | Within 5 min[1] |
Duration of action | 8 hrs[1] |
External links | |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604011 |
Pharmacokinetics | |
Protein binding | 64% |
Elimination half-life | 12 hours |
Chemical and physical data | |
Formula | C16H15N3 |
Molar mass | 249.317 g·mol−1 |
3D model (JSmol) | |
| |
|
Epinastine, sold under the brand name Elestat among others, is a medication used to treat allergic conjunctivitis.[1] It is used as an eye drop.[1] Effects begin within 5 minutes and last for up to 8 hours.[1] It may be used for up to 8 weeks.[2]
Common side effects include eye irritation.[2] Other side effects may include dry eye and change in taste.[2] It is an antihistamine and mast cell stabilizer.[1] It does not cross the blood-brain-barrier.[1]
Epinastine was patented in 1980 and came into medical use in 1994.[3] In the United Kingdom 5 ml cost the NHS about £10 as of 2021.[2] This amount in the United States costs about 31 USD.[4]
Medical uses
Dosage
It is used as one drop twice per day.[2][1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 "Epinastine Monograph for Professionals". Drugs.com. Archived from the original on 1 March 2021. Retrieved 15 December 2021.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1205. ISBN 978-0857114105.
- ↑ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 549. ISBN 9783527607495. Archived from the original on 2020-12-27. Retrieved 2021-03-08.
- ↑ "Epinastine Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 8 May 2016. Retrieved 15 December 2021.
External links
Identifiers: |
|
---|
Categories:
- Pages using duplicate arguments in template calls
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Azepanes
- H1 receptor antagonists
- Guanidines
- AbbVie brands
- Mast cell stabilizers
- Peripherally selective drugs
- RTT